Please login to the form below

Not currently logged in
Email:
Password:

Rydapt

This page shows the latest Rydapt news and features for those working in and with pharma, biotech and healthcare.

Astellas stays ahead of its FLT3 rivals with EU nod for Xospata

Astellas stays ahead of its FLT3 rivals with EU nod for Xospata

It is however the second drug in the class to be approved for marketing after Novartis’  Rydapt (midostaurin), which was cleared for newly-diagnosed FLT3-positive AML in the US and ... head study with Rydapt.

Latest news

More from news
Approximately 4 fully matching, plus 9 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics